A local study led by the Agency for Science, Technology and Research (A*STAR) discovered that by inhibiting the function of two proteins, G9a and GLP, during the cell therapy production process, immune cells could become ...
Jul 10, 2023
0
59
Autologous conditioned serum (ACS)—a biologic therapy that famous athletes swear by to treat arthritis and sports injuries—also shows benefit for the kind of neurological pain caused by chemotherapy or diabetes.
May 23, 2023
0
76
Atopic dermatitis (AD) is a chronic inflammatory disease most commonly seen in children and adults. The condition seriously affects patients' quality of life. Its prevalence rate worldwide is 7%–30% in children and 1%–10% ...
May 17, 2023
0
2
A new research paper titled "AAV1.NT-3 gene therapy prevents age-related sarcopenia" has been published in Aging.
Mar 15, 2023
0
5
Controversies surrounding hormone therapy (HT) and its benefits and risks have dominated the women's health field for more than 2 decades. A large new study demonstrates that, despite some commonly held misperceptions, HT ...
Mar 1, 2023
0
8
Teaching the body's immune cells to recognize and fight cancer is one of the holy grails in medicine. Over the past two decades, researchers have developed new immunotherapy drugs that stimulate a patient's immune cells to ...
Dec 16, 2022
0
3
The effect of medicines on women and men can differ significantly. This also applies to the currently most promising anti-aging drug rapamycin, as researchers from the Max Planck Institute for Biology of Ageing in Cologne ...
Dec 1, 2022
0
184
Engineered immune cells, known as CAR T cells, have shown the world what personalized immunotherapies can do to fight blood cancers. Now, investigators have reported highly promising early results for CAR T therapy in a small ...
Nov 23, 2022
0
913
A new research paper titled "IGF1 gene therapy in middle-aged female rats delays reproductive senescence through its effects on hypothalamic GnRH and kisspeptin neurons" has been published in Aging.
Nov 16, 2022
0
8
Researchers at the University of Michigan Rogel Cancer Center have identified a novel treatment approach to an aggressive type of pediatric brain cancer, using therapies already approved to treat cancer.
Nov 15, 2022
0
23
